Bret
Fuller was a postdoc on the UMARC training grant. He now work
at the Oregon Health Science University in Portland, Oregon
in the Department of Public Health and Preventative Medicine.
Dr. Fuller is a member of the Oregon Node of the Clinical
Trials Network, a research network sponsored by the National
Institute on Drug Abuse that examines treatment approaches
to substance abuse. He is the lead coordinator for the Baseline
Study which surveys all the treatment units in the CTN. He
is also a project manager for a CTN protocol entitled "HIV
and HCV RISK REDUCTION INTERVENTIONS IN DRUG DETOXIFICATION
AND TREATMENT SETTINGS" that examines strategies for
moving detoxification completers into long term substance
abuse treatment. Dr. Fuller is also working with the Cascade
AIDS Project in Portland to examine prevention approaches
to reducing HIV risk behaviors in gay and bisexual men and
people of color.
Bret
Fuller was a postdoc on the UMARC training grant. He now work
at the Oregon Health Science University in Portland, Oregon
in the Department of Public Health and Preventative Medicine.
Dr. Fuller is a member of the Oregon Node of the Clinical
Trials Network, a research network sponsored by the National
Institute on Drug Abuse that examines treatment approaches
to substance abuse. He is the lead coordinator for the Baseline
Study which surveys all the treatment units in the CTN. He
is also a project manager for a CTN protocol entitled "HIV
and HCV RISK REDUCTION INTERVENTIONS IN DRUG DETOXIFICATION
AND TREATMENT SETTINGS" that examines strategies for
moving detoxification completers into long term substance
abuse treatment. Dr. Fuller is also working with the Cascade
AIDS Project in Portland to examine prevention approaches
to reducing HIV risk behaviors in gay and bisexual men and
people of color.
